.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Julphar
Covington
Citi
US Army
Queensland Health
Boehringer Ingelheim
Accenture
Novartis

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040616

« Back to Dashboard

NDA 040616 describes WARFARIN SODIUM, which is a drug marketed by Amneal Pharms, Barr, Invagen Pharms, Ipca Labs Ltd, Mylan, Pliva, Sandoz, Taro Pharm, Usl Pharma, Watson Labs, and Zydus Pharms Usa, and is included in seventeen NDAs. It is available from thirty-two suppliers. Additional details are available on the WARFARIN SODIUM profile page.

The generic ingredient in WARFARIN SODIUM is warfarin sodium. There are twenty-two drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.

Summary for 040616

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 040616

Mechanism of ActionVitamin K Inhibitors

Suppliers and Packaging for NDA: 040616

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
WARFARIN SODIUM warfarin sodium TABLET;ORAL 040616 ANDA Teva Pharmaceuticals USA, Inc. 0093-1712 0093-1712-01 100 TABLET in 1 BOTTLE (0093-1712-01)
WARFARIN SODIUM warfarin sodium TABLET;ORAL 040616 ANDA Teva Pharmaceuticals USA, Inc. 0093-1712 0093-1712-10 1000 TABLET in 1 BOTTLE (0093-1712-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Jul 5, 2006TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Jul 5, 2006TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength3MG
Approval Date:Jul 5, 2006TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
QuintilesIMS
Healthtrust
Medtronic
Fuji
Argus Health
AstraZeneca
Farmers Insurance
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot